Hypermarcas (OTCMKTS:HYPMY) Trading Down 9% – What’s Next?

Hypermarcas (OTCMKTS:HYPMY) shares traded down 9% during mid-day trading on Tuesday . The stock traded as low as $4.25 and last traded at $4.25. 413 shares were traded during trading, a decline of 88% from the average session volume of 3,427 shares. The stock had previously closed at $4.67.

Hypermarcas Stock Performance

The stock has a 50 day moving average of $4.51 and a 200 day moving average of $4.44. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The firm has a market cap of $3.19 billion, a price-to-earnings ratio of 21.91 and a beta of 0.72.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings data on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. The firm had revenue of $408.83 million for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.